<DOC>
<DOCNO>
EP-0016310
</DOCNO>
<TEXT>
<DATE>
19801001
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 A61P-9/00 A61K-31/66 <main>C07F-9/38</main> C07F-9/38 A61P-3/08 A61P-3/00 A61P-9/10 C07F-9/40 
</IPC-CLASSIFICATIONS>
<TITLE>
monophosphonate compounds, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
symphar sach<sep>symphar s.a.<sep>symphar s.a.243, route des fayardsch-1290 versoixch<sep>symphar s.a.<sep>
</APPLICANT>
<INVENTOR>
nguyen mong lan<sep>nguyen mong, lan<sep>nguyen mong, lan7, chemin du pré-fleurich-1260 nyon, vaudch<sep>nguyen mong, lan<sep>nguyen mong, lan7, chemin du pré-fleurich-1260 nyon, vaudch<sep>
</INVENTOR>
<ABSTRACT>
this invention relates to new monophosphonate com­ pounds of formula x-c₆h₄-(o)m-(ch₂)n-r where r is -po₃me₂,  -po₃et₂, -po₃h₂ or -po₃na₂, x is a halogen, preferably  chlorine, in position o, m or p, preferably in position p; m is 0  or 1; and n is 0, 1, 2, 3, 4, 5 or 6, which possess remarkable  activity as hypoglycemic and/or antiatherogenic agents, and  are usable in pharmaceutical compositions to alter lipopro­ tein profiles in favour of high density lipoproteins and to clear  cholesterol from various tissues.  
</ABSTRACT>
</TEXT>
</DOC>
